Abstract
Objective
Assess if maternal betamethasone administration at 34–35 weeks accelerated neonatal amplitude integrated EEG (aEEG) maturation.
Study design
Nested, observational cohort in 7 centers participating in the Antenatal Late Preterm Steroid randomized trial. Up to 2 aEEGs were obtained in neonates born from 340–356 weeks gestation before 72 h (aEEG 1) and at 5–7 days (aEEG 2) if hospitalized. Personnel and aEEG central readers were masked to the intervention. The primary outcome was maturation reflected by cycle frequency; secondary outcomes were border voltage, span, and discontinuity.
Results
58 neonates were enrolled (betamethasone, 28, placebo, 30). On aEEG 1, cycle frequency did not differ, but betamethasone exposed infants had a greater lower border voltage and a broader span. On aEEG 2, both groups displayed increases in lower border voltage.
Conclusions
Betamethasone associated changes in lower border voltage support accelerated electrical activity. Further investigation is needed to understand the broader span.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Data reported in this paper may be requested through a data use agreement. Further details are available at https://neonatal.rti.org/index.cfm?fuseaction=DataRequest.Home.
References
Raju TN, Higgins RD, Stark AR, Leveno KJ. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics. 2006;118:1207–14.
Kugelman A, Colin AA. Late preterm infants: near term but still in a critical developmental time period. Pediatrics. 2013;132:741–51.
Engle WA, Tomashek KM, Wallman C. “Late-preterm” infants: a population at risk. Pediatrics. 2007;120:1390–401.
Kinney HC. The near-term (late preterm) human brain and risk for periventricular leukomalacia: a review. Semin Perinatol. 2006;30:81–8.
Kapellou O, Counsell SJ, Kennea N, Dyet L, Saeed N, Stark J, et al. Abnormal cortical development after premature birth shown by altered allometric scaling of brain growth. PLoS Med. 2006;3:e265.
Huppi PS, Warfield S, Kikinis R, Barnes PD, Zientara GP, Jolesz FA, et al. Quantitative magnetic resonance imaging of brain development in premature and mature newborns. Ann Neurol. 1998;43:224–35.
Burdjalov VF, Baumgart S, Spitzer AR. Cerebral function monitoring: a new scoring system for the evaluation of brain maturation in neonates. Pediatrics. 2003;112:855–61.
Sommers R, Tucker R, Harini C, Laptook AR. Neurological maturation of late preterm infants at 34 wk assessed by amplitude integrated electroencephalogram. Pediatr Res. 2013;74:705–11.
Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita AT, Reddy UM, Saade GR, et al. Antenatal betamethasone for women at risk for late preterm delivery. N. Engl J Med. 2016;374:1311–20.
Hellstrom-Westas L. Amplitude-integrated EEG classification and interpretation in preterm and term infants. NeoReviews. 2006;7:e76–e87.
Darnall RA, Ariagno RL, Kinney HC. The late preterm infant and the control of breathing, sleep, and brainstem development: a review. Clin Perinatol. 2006;33:883–914.
Gewolb IH, Vice FL. Maturational changes in the rhythms, patterning, and coordination of respiration and swallow during feeding in preterm and term infants. Dev Med Child Neurol. 2006;48:589–94.
McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22:276–82.
Soubasi V, Mitsakis K, Nakas CT, Petridou S, Sarafidis K, Griva M, et al. The influence of extrauterine life on the aEEG maturation in normal preterm infants. Early Hum Dev. 2009;85:761–5.
Kato T, Okumura A, Hayakawa F, Tsuji T, Natsume J, Watanabe K. Evaluation of brain maturation in pre-term infants using conventional and amplitude-integrated electroencephalograms. Clin Neurophysiol. 2011;122:1967–72.
Kuint J, Turgeman A, Torjman A, Maayan-Metzger A. Characteristics of amplitude-integrated electroencephalogram in premature infants. J Child Neurol. 2007;22:277–81.
Kidokoro H, Inder T, Okumura A, Watanabe K. What does cyclicity on amplitude-integrated EEG mean? J Perinatol. 2012;32:565–9.
Thornberg E, Thiringer K. Normal pattern of the cerebral function monitor trace in term and preterm neonates. Acta Paediatr Scand. 1990;79:20–5.
Sisman J, Campbell DE, Brion LP, Amplitude-integrated EEG. in preterm infants: maturation of background pattern and amplitude voltage with postmenstrual age and gestational age. J Perinatol. 2005;25:391–6.
Zhang D, Liu Y, Hou X, Zhou C, Luo Y, Ye D, et al. Reference values for amplitude-integrated EEGs in infants from preterm to 3.5 months of age. Pediatrics. 2011;127:e1280–1287.
Cui H, Ding Y, Yu Y, Yang L. Changes of amplitude integration electroencephalogram (aEEG) in different maturity preterm infant. Childs Nerv Syst. 2013;29:1169–76.
Niemarkt HJ, Jennekens W, Maartens IA, Wassenberg T, van Aken M, Katgert T, et al. Multi-channel amplitude-integrated EEG characteristics in preterm infants with a normal neurodevelopment at two years of corrected age. Early Hum Dev. 2012;88:209–16.
Shany E, Berger I, Goldberg O, Karplus M, Gilat S, Benzaquen O, et al. Do prenatal corticosteroids affect brain maturation of the premature infant? An electroencephalography study. Clin EEG Neurosci. 2017;48:79–87.
Meledin I, Abu Tailakh M, Gilat S, Yogev H, Golan A, Novack V, et al. Comparison of amplitude-integrated EEG and conventional EEG in a cohort of premature infants. Clin EEG Neurosci. 2017;48:146–54.
Vesoulis ZA, Paul RA, Mitchell TJ, Wong C, Inder TE, Mathur AM. Normative amplitude-integrated EEG measures in preterm infants. J Perinatol. 2015;35:428–33.
Yerushalmy-Feler A, Marom R, Peylan T, Korn A, Haham A, Mandel D, et al. Electroencephalographic characteristics in preterm infants born with intrauterine growth restriction. J Pediatr. 2014;164:756–761 e751.
Davidson JO, Quaedackers JS, George SA, Gunn AJ, Bennet L. Maternal dexamethasone and EEG hyperactivity in preterm fetal sheep. J Physiol. 2011;589:3823–35.
Schwab M, Schmidt K, Roedel M, Mueller T, Schubert H, Anwar MA, et al. Non-linear changes of electrocortical activity after antenatal betamethasone treatment in fetal sheep. J Physiol. 2001;531:535–43.
Schneider U, Arnscheidt C, Schwab M, Haueisen J, Seewald HJ, Schleussner E. Steroids that induce lung maturation acutely affect higher cortical function: a fetal magnetoencephalography study. Reprod Sci. 2011;18:99–106.
O’Toole JM, Pavlidis E, Korotchikova I, Boylan GB, Stevenson NJ. Temporal evolution of quantitative EEG within 3 days of birth in early preterm infants. Sci Rep. 2019;9:4859.
Acknowledgements
The National Institutes of Health, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Heart, Lung, and Blood Institute, and the National Center for Advancing Translational Sciences provided grant support for the Maternal-Fetal Medicine Units Network’s ALPS trial and the Neonatal Research Network’s aEEG secondary study. NICHD staff provided input into the study design, conduct, analysis, and manuscript drafting; NCATS cooperative agreements provided infrastructure support to the NRN. While NICHD staff had input into the study design, conduct, analysis, and manuscript drafting, the comments and views of the authors do not necessarily represent the views of NICHD, the National Institutes of Health, the Department of Health and Human Services, or the U.S. Government. Data collected at participating sites of the NICHD Neonatal Research Network (NRN) were transmitted to RTI International, the data coordinating center (DCC) for the network, which stored, managed and analyzed the data included in this study. On behalf of the NRN, RTI International had full access to all the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We are indebted to our medical and nursing colleagues and the infants and their parents who agreed to take part in this study. The investigators below, in addition to those listed as authors, participated in this study.
Funding
Financial support was provided by NICHD Cooperative Multicenter Neonatal Research Network, UG1HD027904 and the NICHD Cooperative Multicenter Maternal-Fetal Medicine Units Network, U10HD036801. ClinicalTrials.gov ID ALPS: NCT01222247.
Author information
Authors and Affiliations
Consortia
Contributions
ARL, MD made substantial contributions to the conception of the work, acquisition and interpretation of the data, drafting the manuscript, approved the submitted version and is personally accountable for the manuscript. LC, MD made substantial contributions to the conception of the work, acquisition and interpretation of the data, drafting the manuscript, approved the submitted version and is personally accountable for the manuscript. AP, MD made substantial contributions to the conception of the work, acquisition and interpretation of the data, drafting the manuscript, approved the submitted version and is personally accountable for the manuscript. AD, MD made contribution to the acquisition of the data, editing the manuscript, approved the submitted version and is personally accountable for the manuscript. PJS, MD made contribution to the acquisition of the data, editing the manuscript, approved the submitted version and is personally accountable for the manuscript. KPVM made contribution to the acquisition of the data, editing the manuscript, approved the submitted version and is personally accountable for the manuscript. WO, MD made substantial contributions to the conception of the work, interpretation of the data, editing the manuscript, approved the submitted version and is personally accountable for the manuscript. RS, MD made substantial contributions to the conception of the work, interpretation of the data, editing the manuscript, approved the submitted version and is personally accountable for the manuscript. SS, MD made substantial contributions to the conception of the work, interpretation of the data, review of the manuscript, approved the submitted version and is personally accountable for the manuscript. AMH, PhD, RNC-NIC made contribution to the acquisition of the data, editing the manuscript, approved the submitted version and is personally accountable for the manuscript. DJR, MD made substantial contributions to the conception of the work, interpretation of the data, review of the manuscript, approved the submitted version and is personally accountable for the manuscript. SM, BS made substantial contributions to the conception of the work, interpretation of the data, analysis of the data, editing the manuscript, approved the submitted version and is personally accountable for the manuscript. AD, PhD made substantial contributions to the conception of the work, interpretation of the data, analysis of the data, editing the manuscript, approved the submitted version and is personally accountable for the manuscript. RNG, MD made contribution to the acquisition of the data, editing the manuscript, approved the submitted version and is personally accountable for the manuscript. NA, MD made contribution to the acquisition of the data, editing the manuscript, approved the submitted version and is personally accountable for the manuscript. CGB, MD made substantial contributions to the conception of the work, interpretation of the data, review of the manuscript, approved the submitted version and is personally accountable for the manuscript. EAT, MD made substantial contributions to the conception of the work, interpretation of the data, review of the manuscript, approved the submitted version and is personally accountable for the manuscript. RDH, MD made substantial contributions to the conception of the work, interpretation of the data, review of the manuscript, approved the submitted version and is personally accountable for the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Laptook, A.R., Chalak, L., Pappas, A. et al. The effects of betamethasone on the amplitude integrated EEG of infants born at 34- or 35-weeks gestation. J Perinatol 42, 1615–1621 (2022). https://doi.org/10.1038/s41372-022-01415-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41372-022-01415-4